NeuroVista
NeuroVista Corporation was founded in 2002 by Dr. Leonidas Iasemidis and Dr. Daniel DiLorenzo as an early-stage medical device company that specialized in the management and treatment of epilepsy, including a novel Seizure Advisory System.[1][2][3][4]
Based in Seattle, Washington, NeuroVista was previously known as NeuroBionics Corporation,[5] and subsequently went through six rounds of financing totaling $61.3M USD.[6]
In 2010, Cyberonics announced that it had entered into technology agreements with NeuroVista.[7]
NeuroVista shut down operations in 2013.[citation needed]
References[edit]
- ↑ Seattle 40 Under 40 - DiLorenzo's Early Tinkering leads to a Medical Device company
- ↑ NeuroVista Publishes Study Results for their Implantable Seizure-Warning Device
- ↑ NeuroVista’s Implantable EEG for Seizure Prediction
- ↑ Form D filing with the U.S. Securities and Exchange Commission
- ↑ BioNeuronics Founder (now NeuroVista)
- ↑ VentureBeat on NeuroVista Founder & Financing
- ↑ Cyberonics Announces Epilepsy Technology Agreements
This article "NeuroVista" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:NeuroVista. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
